Markets

Raptor Pharmaceuticals (RPTP) Jumps: Stock Adds 28.2% in Session - Tale of the Tape

Raptor Pharmaceuticals Corp. ( RPTP ) was a big mover last session, as its shares rose over 28% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $8.09 to $10.49 in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revisions and the Zacks Consensus Estimate also remained unchanged. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Raptor Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Other better-ranked stocks in the med-drugs industry include Actelion Ltd. ( ALIOF ), Cambrex Corporation. ( CBM ) and Curis, Inc. ( CRIS ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RAPTOR PHARMACT (RPTP): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

CURIS INC (CRIS): Free Stock Analysis Report

ACTELION LTD (ALIOF): Get Free Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CRIS

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More